Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

NCT01269047 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Pramlintide
DRUG: Exenatide
DRUG: Insulin

Sponsor

Albert Einstein College of Medicine

Collaborators

[object Object]